Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$891.11
-2.8%
$918.89
$754.00
▼
$1,153.99
$263.51B1.292.10 million shs4.66 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$28.84
-0.2%
$28.81
$23.62
▼
$31.44
$164.33B0.3135.57 million shs30.83 million shs
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$84.85
-1.4%
$84.11
$72.78
▼
$97.76
$257.44B0.9313.48 million shs9.16 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
0.00%+5.79%+4.04%-12.82%+15.87%
Pfizer Inc. stock logo
PFE
Pfizer
0.00%-1.68%-2.33%+7.47%+15.20%
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
0.00%+2.42%+2.62%-1.75%+1.22%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$891.11
-2.8%
$918.89
$754.00
▼
$1,153.99
$263.51B1.292.10 million shs4.66 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$28.84
-0.2%
$28.81
$23.62
▼
$31.44
$164.33B0.3135.57 million shs30.83 million shs
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$84.85
-1.4%
$84.11
$72.78
▼
$97.76
$257.44B0.9313.48 million shs9.16 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
0.00%+5.79%+4.04%-12.82%+15.87%
Pfizer Inc. stock logo
PFE
Pfizer
0.00%-1.68%-2.33%+7.47%+15.20%
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
0.00%+2.42%+2.62%-1.75%+1.22%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
2.42
Hold$1,052.0418.06% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.18
Hold$30.325.12% Upside
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
2.65
Moderate Buy$97.5014.92% Upside

Current Analyst Ratings Breakdown

Latest PFE, GS, and WFC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/12/2026
Pfizer Inc. stock logo
PFE
Pfizer
Reiterated RatingMarket Perform$29.00
11/9/2026
Pfizer Inc. stock logo
PFE
Pfizer
UpgradeHold (C) ➝ Hold (C+)
11/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
Set Price Target$34.00
11/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
Boost Price TargetBuy$33.00 ➝ $34.00
11/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
DowngradeBuy ➝ Hold
11/5/2026
Pfizer Inc. stock logo
PFE
Pfizer
Boost Price TargetBuy$31.00 ➝ $33.00
11/4/2026
Pfizer Inc. stock logo
PFE
Pfizer
Set Price Target$40.00
11/4/2026
Pfizer Inc. stock logo
PFE
Pfizer
Boost Price TargetNeutral$27.00 ➝ $30.00
11/4/2026
Pfizer Inc. stock logo
PFE
Pfizer
Boost Price TargetSector Outperform$33.00 ➝ $35.00
11/4/2026
Pfizer Inc. stock logo
PFE
Pfizer
Boost Price TargetNeutral$27.00 ➝ $30.00
11/2/2026
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Lower Price TargetNeutral$1,010.00 ➝ $1,000.00
(Data available from 11/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$125.10B2.05$62.98 per share14.15$381.89 per share2.33
Pfizer Inc. stock logo
PFE
Pfizer
$62.58B2.63$4.40 per share6.56$15.67 per share1.84
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$123.53B2.06$9.17 per share9.25$53.56 per share1.58
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$17.18B$69.5513.1412.060.8515.77%20.21%1.08%1/19/2027 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$7.77B$0.709.459.741.896.34%19.88%8.52%2/2/2027 (Estimated)
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$21.34B$7.0911.9910.580.9217.64%14.05%1.04%1/14/2027 (Estimated)

Latest PFE, GS, and WFC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/3/2026Q3 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.7350$0.87+$0.1350$0.56$15.85 billion$16.58 billion
10/13/2026Q3 2026
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$12.86$17.01+$4.15$17.01$16.83 billion$18.68 billion
10/13/2026Q3 2026
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$1.85$1.87+$0.02$1.87$22.30 billion$21.87 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$20.002.24%+22.87%28.76%13 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.725.96%-13.20%245.71%16 Years
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
$2.002.36%+6.86%28.21%4 Years

Latest PFE, GS, and WFC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/12/2026
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
quarterly$5.002.24%12/2/202612/2/202612/30/2026
10/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.435.85%11/6/202611/6/202612/7/2026
10/27/2026
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
quarterly$0.502.38%11/6/202611/6/202612/1/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
3.20
0.61
0.61
Pfizer Inc. stock logo
PFE
Pfizer
0.67
1.42
1.10
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
1.14
0.89
0.89

Institutional Ownership

CompanyInstitutional Ownership
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
71.21%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
75.90%

Insider Ownership

CompanyInsider Ownership
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
0.55%
Pfizer Inc. stock logo
PFE
Pfizer
0.62%
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
0.14%
CompanyEmployeesShares OutstandingFree FloatOptionable
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
47,400288.43 million286.85 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
75,0005.70 billion5.66 billionOptionable
Wells Fargo & Company stock logo
WFC
Wells Fargo & Company
205,0003.00 billion3.00 billionOptionable

Recent News About These Companies

Chase and other major banks hit by online outages
Zelle picks Solana for ZelleUSD stablecoin and international payments
Cogent Communications drops after Wells Fargo turns Underweight
Wells Fargo Downgraded Hartford (HIG). What Changed in Commercial?
Wells Fargo & Company Declares Cash Dividends on Preferred Stock
Wells Fargo Eyes $50B NII in 2026: What's Fuelling the Optimism?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
The Goldman Sachs Group stock logo

The Goldman Sachs Group NYSE:GS

$891.11 -25.45 (-2.78%)
Closing price 03:59 PM Eastern
Extended Trading
$893.62 +2.51 (+0.28%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

The Goldman Sachs Group, Inc., a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals worldwide. It operates through Global Banking & Markets, Asset & Wealth Management, and Platform Solutions segments. The Global Banking & Markets segment provides financial advisory services, including strategic advisory assignments related to mergers and acquisitions, divestitures, corporate defense activities, restructurings, and spin-offs; and relationship lending, and acquisition financing, as well as secured lending, through structured credit and asset-backed lending and involved in financing under securities to resale agreements. This segment also offers client execution activities for cash and derivative instruments; credit and interest rate products; and provision of mortgages, currencies, commodities, and equities related products, as well as underwriting services. The Asset & Wealth Management segment manages assets across various classes, including equity, fixed income, hedge funds, credit funds, private equity, real estate, currencies, and commodities; and provides customized investment advisory solutions, wealth advisory services, personalized financial planning, and private banking services, as well as invests in corporate equity, credit, real estate, and infrastructure assets. The Platform Solutions segment offers credit cards and point-of-sale financing for purchase of goods or services. This segment also provides cash management services, such as deposit-taking and payment solutions for corporate and institutional clients. The Goldman Sachs Group, Inc. was founded in 1869 and is headquartered in New York, New York.

Pfizer stock logo

Pfizer NYSE:PFE

$28.84 -0.05 (-0.18%)
Closing price 03:59 PM Eastern
Extended Trading
$28.86 +0.02 (+0.08%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Wells Fargo & Company stock logo

Wells Fargo & Company NYSE:WFC

$84.84 -1.21 (-1.40%)
Closing price 03:59 PM Eastern
Extended Trading
$84.72 -0.12 (-0.14%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Wells Fargo & Co. is a diversified and community-based financial services company, which engages in the provision of banking, insurance, investments, mortgage, and consumer and commercial finance products and services. It operates through the following segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth and Investment Management. The Consumer Banking and Lending segment offers consumer and small business banking, home lending, credit cards, auto, and personal lending. The Commercial Banking segment provides banking and credit products across industry sectors and municipalities, secured lending and lease products, and treasury management. The Corporate and Investment Banking segment is composed of corporate banking, investment banking, treasury management, commercial real estate lending and servicing, and equity and fixed income solutions, as well as sales, trading, and research capabilities. The Wealth and Investment Management segment refers to personalized wealth management, brokerage, financial planning, lending, private banking, trust, and fiduciary products and services. The company was founded by Henry Wells and William G. Fargo on March 18, 1852 and is headquartered in San Francisco, CA.